Implications of lipid raft disintegration: Enhanced anti-inflammatory macrophage phenotype

被引:25
作者
Cuschieri, J [1 ]
机构
[1] Univ Cincinnati, Dept Surg, Cincinnati, OH 45221 USA
关键词
D O I
10.1016/j.surg.2004.04.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Lipid rafts are membrane microdomains characterized by an enriched cholesterol environment and appear to serve as a platform for signaling. Their role within the macrophage during endotoxin exposure is unknown. Methods. THP-1 cells were subjected to lipopolysaccharide stimulation with or without methyl-beta-cyclodextrin (MbetaCD) pretreatment, a cholesterol depleting agent. Cell surface expression of toll-like receptor-4 (TLR4) and platelet-activating factor receptor (PAFr) was determined by flow cytometry. Membrane receptor components and activation of the mitogen-activated protein kinases (MAPK) was determined from lipid raft and cellular protein by immunoblot. Inflammatory mediator production was determined from harvested supernatants by enzyme-linked immunosorbent assay. Results. Surface expression of TLR4 and PAFr was not affected by MbetaCD. Lipopolysaccharide stimulation led to TLR4 mobilization to lipid rafts, MAPK activation, and inflammatory mediator Production. Pretreatment with MbetaCD did not affect TLR4 mobilization to lipid rafts, but did result in lost lipid raft expression of the PAFr coupled G-Protein, Galpha(1). MbetaCD treatment led to selective attenuation of MAPK activation through ERK 1/2. This dysregulated signaling was associated with attenuated production of tumor necrosis factor-a, but increased production of interleukin-10. Conclusion. Lipid raft disintegration results in lost expression of Gal, dysregulated MAPK signaling, and selective anti-inflammatory mediator production. Therefore, modulation of lipid raft cholesterol content may represent a potential mechanism for regulation of macrophage phenotypic differentiation.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 19 条
[1]   Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation [J].
Adib-Conquy, M ;
Moine, P ;
Asehnoune, K ;
Edouard, A ;
Espevik, T ;
Miyake, K ;
Werts, C ;
Cavaillon, JM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :158-164
[2]   Sepsis and evolution of the innate immune response [J].
Beutler, B ;
Poltorak, A .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S2-S6
[3]   DIVERSITY IN FUNCTION AND REGULATION OF MAP KINASE PATHWAYS [J].
BLUMER, KJ ;
JOHNSON, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (06) :236-240
[4]   Platelet-activating factor acetylhydrolase inhibits alveolar macrophage activation in vivo [J].
Bulger, EM ;
Gourlay, D ;
Cuschieri, J ;
Jelacic, S ;
Staudenmeyer, K ;
Garcia, I ;
Maier, RV .
SHOCK, 2003, 20 (01) :17-22
[5]   GRAM-NEGATIVE BACTERIAL SEPSIS AND SEPSIS SYNDROME [J].
DUNN, DL .
SURGICAL CLINICS OF NORTH AMERICA, 1994, 74 (03) :621-635
[6]   Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex [J].
Fujihara, M ;
Muroi, M ;
Tanamoto, K ;
Suzuki, T ;
Azuma, H ;
Ikeda, H .
PHARMACOLOGY & THERAPEUTICS, 2003, 100 (02) :171-194
[7]   LPS induction of gene expression in human monocytes [J].
Guha, M ;
Mackman, N .
CELLULAR SIGNALLING, 2001, 13 (02) :85-94
[8]   LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN ACCELERATES THE BINDING OF LPS TO CD14 [J].
HAILMAN, E ;
LICHENSTEIN, HS ;
WURFEL, MM ;
MILLER, DS ;
JOHNSON, DA ;
KELLEY, M ;
BUSSE, LA ;
ZUKOWSKI, MM ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :269-277
[9]  
Jarrar D, 1999, INT J MOL MED, V4, P575
[10]   CELLULAR CHOLESTEROL EFFLUX MEDIATED BY CYCLODEXTRINS [J].
KILSDONK, EPC ;
YANCEY, PG ;
STOUDT, GW ;
BANGERTER, FW ;
JOHNSON, WJ ;
PHILLIPS, MC ;
ROTHBLAT, GH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17250-17256